Paragon Care Limited (ASX:PGC): Healthcare Distribution and FY26 Operating Performance

Aditi Sarkar

30 October 2026 08:16 PM AEDT

Paragon Care Limited (ASX:PGC): Healthcare Distribution and FY26 Operating Performance

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

FY26 underlying revenue reached $3.7 billion, according to the company’s investor centre.
FY26 underlying EBITDA was $97.2 million, with underlying NPAT of $26 million.
The group supplies healthcare products and equipment across Asia Pacific markets.
The business completed the final stages of its integration programme during FY26.

Paragon Care Limited (ASX:PGC) is a healthcare wholesaler, distributor and manufacturer serving customers across the Asia Pacific region. The group’s FY26 performance reflected the interaction between healthcare distribution activity, business integration and the cost of supporting a broad product offering. Its investor centre reports underlying revenue of $3.7 billion, underlying EBITDA of $97.2 million and underlying net profit after tax of $26 million for FY26. These figures provide an overview of the scale of the business, but they measure different aspects of performance.

How the Business Is Organised

Paragon Care Limited (ASX:PGC) supplies pharmaceuticals, diagnostic products, medical consumables and devices, capital equipment and related healthcare products. These activities involve different purchasing patterns and customer needs, making distribution execution a significant part of its operating model. Revenue is associated with the movement of products through a complex healthcare supply chain, while earnings depend on operating costs and the profitability of the goods and services delivered. The company’s breadth of activities also means that changes in one category do not necessarily describe conditions throughout the entire business. Its FY26 disclosures place integration and operational coordination alongside financial outcomes rather than treating revenue as the only measure of progress.

Integration and Execution in FY26

Paragon Care Limited (ASX:PGC) described FY26 as a year in which it completed the final stages of a major integration programme. That work matters because combining distribution activities requires consistent systems, facilities, product information and customer service processes. The company’s first-half FY26 release recorded revenue of $1.9 billion, up 2.9% on the prior comparable period, and underlying EBITDA of $49.0 million, up 3.1%. Underlying NPAT for that half was $13.3 million, up 0.7%. These measures show a relatively narrow change in first-half earnings compared with the increase in sales, an important distinction when considering the wider annual figures.

What the Figures Show

Paragon Care Limited (ASX:PGC) reported that its first-half FY26 EBITDA margin was 2.57%, unchanged from the prior comparable half. EBITDA and underlying NPAT are not interchangeable: EBITDA precedes certain financing, tax and accounting costs, while net profit is a later measure of earnings. The company’s September 2026 audited financial results release followed its August FY26 results announcement, giving a formal reporting sequence for the annual outcome. A reader comparing those releases should keep the reporting dates and definitions consistent. Comparing half-year totals with full-year totals without identifying the different periods can produce an inaccurate impression of operating trends.

Business Developments and Monitoring Points

Paragon Care Limited (ASX:PGC) reported operating developments in FY26 involving distribution infrastructure and expanded product capabilities. Its first-half update identified the commencement of operations at a purpose-built Willawong distribution centre in Brisbane. It also addressed a provision relating to a pharmacy customer debt, showing how receivables can affect the financial outcome of a distribution business. Such developments are part of the commercial context surrounding the reported income measures. Distribution capacity, working capital requirements, customer payments and integration execution are distinct considerations; none should be inferred directly from a share-price observation at a single moment.

Key Insights

Paragon Care Limited (ASX:PGC) reported substantial FY26 sales alongside underlying EBITDA and net profit that reflect the economics of healthcare distribution. Its FY26 materials also describe completion of major integration work and the operation of distribution facilities. Taken together, these facts show why annual revenue, earnings definitions and operational execution need to be considered separately. The $0.15 share price recorded on 30 October 2026 is a dated trading observation rather than a measure of annual operating performance.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.